Genetic Technologies
GENE
#10486
Rank
$3.7 M
Marketcap
$0.76
Share price
0.00%
Change (1 day)
-68.65%
Change (1 year)

EPS for Genetic Technologies (GENE)

EPS in 2018 (TTM): N/A

In 2023 the company made an earnings per share (EPS) of -$0.03325 a decrease over its 2022 EPS that were of -$0.02207.

EPS history for Genetic Technologies from 2001 to 2018

Annual EPS

Year EPS Change
2023-$0.0332550.65%
2022-$0.02207-99.04%
2021-$2.29-46.67%
2020-$4.30-99.38%
2019-$688.0010809.09%
2018-$6.31-41.07%
2017-$10.70-18.37%
2016-$13.11-40.24%
2015-$21.94-53.41%
2014-$47.09-10.66%
2013-$52.7171.3%
2012-$30.77-622.73%
2011$5.89-108.8%
2010-$66.89-3.92%
2009-$69.6273.47%
2008-$40.1324.96%
2007-$32.12-10.93%
2006-$36.06-48.62%
2005-$70.18-8.31%
2004-$76.54
2003N/A-100%
2002-$47.52-9.36%
2001-$52.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
-$76.71N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-$4.33N/A๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
$10.25N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
$8.64N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-$0.30N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
$4.88N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$17.34N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-$4.81N/A๐Ÿ‡บ๐Ÿ‡ธ USA